Remdesivir included in 'investigational therapy' for restricted emergency use on COVID-19 patients: Health Ministry

Jun 14, 2020

New Delhi [India], June 14 : Union Health Ministry on Sunday said that drug Remdesivir has been included as an "investigational therapy" only for...

Gilead's anti-viral remdesivir gets FDA emergency use authorisation for treatment of COVID-19

May 02, 2020

California [USA], May 2 : US-based biopharmaceutical major Gilead Sciences said that the US Food and Drug Administration (FDA) has granted emergency use authorisation...

Zydus signs licensing agreement with Gilead to manufacture and market Remdesivir

Jun 13, 2020

Ahmedabad (Gujarat) [India], June 13 : Healthcare major Zydus Cadila has signed a non-exclusive licensing agreement with Gilead Sciences Inc for the manufacturing and...

Dr Reddy's Labs in licensing pact with Gilead Sciences for Remdesivir

Jun 13, 2020

Hyderabad (Telangana) [India], June 13 : Dr Reddy's Laboratories said on Saturday it has entered into a non-exclusive licensing agreement with Gilead Sciences Inc...

COVID-19: Cipla enters into licensing pact with Gilead to manufacture and distribute Remdesivir

May 13, 2020

Mumbai (Maharashtra) [India], May 13 : Pharmaceutical major Cipla said on Wednesday it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for...

Pfizer begins early stage trial for oral COVID-19 drug

Mar 24, 2021

New York [US], March 24 : Pfizer has said that it has begun early-stage clinical trials of an investigational, oral antiviral drug for Covid-19.